niacinamide has been researched along with Papulosquamous Disorders in 4 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A multicenter prospective observational study was carried out on patients with a diagnosis of mild comedonal-papular facial acne to provide new evidence on the clinical effectiveness, tolerability and acceptability of three salicylic acid-based products for the topical treatment of acne in the daily clinical practice." | 7.96 | Effectiveness of a combination of salicylic acid-based products for the treatment of mild comedonal-papular acne: a multicenter prospective observational study. ( Bettoli, V; Micali, G; Monfrecola, G; Veraldi, S, 2020) |
| "Our patient experienced a diffuse hyperkeratotic rash, hand-foot skin reaction, facial erythema, and stomatitis within three weeks of initiation of sorafenib." | 7.76 | Hyperkeratotic eruption, hand-foot skin reaction, facial erythema, and stomatitis secondary to multi-targeted kinase inhibitor sorafenib. ( Sahai, S; Swick, BL, 2010) |
| "A multicenter prospective observational study was carried out on patients with a diagnosis of mild comedonal-papular facial acne to provide new evidence on the clinical effectiveness, tolerability and acceptability of three salicylic acid-based products for the topical treatment of acne in the daily clinical practice." | 3.96 | Effectiveness of a combination of salicylic acid-based products for the treatment of mild comedonal-papular acne: a multicenter prospective observational study. ( Bettoli, V; Micali, G; Monfrecola, G; Veraldi, S, 2020) |
| "Our patient experienced a diffuse hyperkeratotic rash, hand-foot skin reaction, facial erythema, and stomatitis within three weeks of initiation of sorafenib." | 3.76 | Hyperkeratotic eruption, hand-foot skin reaction, facial erythema, and stomatitis secondary to multi-targeted kinase inhibitor sorafenib. ( Sahai, S; Swick, BL, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bettoli, V | 1 |
| Micali, G | 1 |
| Monfrecola, G | 1 |
| Veraldi, S | 1 |
| Joncas, V | 1 |
| Sammour, R | 1 |
| Krasny, M | 1 |
| Bouffard, D | 1 |
| Provost, N | 1 |
| Sahai, S | 1 |
| Swick, BL | 1 |
| Rodríguez-Vázquez, M | 1 |
| Martinez-Martínez, ML | 1 |
| García-Arpa, M | 1 |
| De Onzoño, LI | 1 |
4 other studies available for niacinamide and Papulosquamous Disorders
| Article | Year |
|---|---|
Effectiveness of a combination of salicylic acid-based products for the treatment of mild comedonal-papular acne: a multicenter prospective observational study.
Topics: Acne Vulgaris; Adult; Carbamide Peroxide; Dermatologic Agents; Drug Combinations; Facial Dermatoses; | 2020 |
A distinct cutaneous reaction to sorafenib and a multikinase inhibitor.
Topics: Administration, Oral; Benzenesulfonates; Biopsy, Needle; Drug Therapy, Combination; Follow-Up Studie | 2008 |
Hyperkeratotic eruption, hand-foot skin reaction, facial erythema, and stomatitis secondary to multi-targeted kinase inhibitor sorafenib.
Topics: Benzenesulfonates; Carcinoma, Renal Cell; Erythema; Humans; Kidney Neoplasms; Male; Middle Aged; Nia | 2010 |
Atypical linear toxicodermia by sorafenib.
Topics: Adult; Benzenesulfonates; Biopsy; Edema; Female; Hepatolenticular Degeneration; Humans; Niacinamide; | 2010 |